Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma

NCT00020111 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

DRUG: arsenic trioxide

Sponsor

National Cancer Institute (NCI)